Tylerdipine Hydrochloride

盐酸泰乐地平

Report date: 2024/06/11 20:00:08
NME

Base Information

Drug NameTylerdipine Hydrochloride
Drug Alias NameKBP-5660
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated L-type calcium channel blockersVoltage-gated T-type calcium channel blockers
TargetsVoltage-gated T-type calcium channelVoltage-gated L-type calcium channel
Therapy Area/IndicationsEssential HypertensionHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesShandong Xuanzhu Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesShandong Xuanzhu Pharmaceutical Technology Co Ltd
Active IndicationsN/A
Inactive IndicationsEssential HypertensionHypertension

Other Information

ATC CodeN/A
Related LinksN/A